VBI Vaccines develops and sells vaccines for immuno-oncology and infectious disease. They offer hepatitis B vaccine under different brand names. The company also has candidates for chronic HBV infection, glioblastoma cancer, cytomegalovirus, and Zika virus treatment. Additionally, they are developing coronavirus vaccine candidates. VBI Vaccines collaborates with Brii Biosciences, the National Research Council of Canada, and Coalition for Epidemic Preparedness Innovations.
| Indicator | Value |
|---|---|
| PER | 100.0 |
| EV/EBITDA | 100.0 |
| Price/Free Cash Flow' | 100.0 |
| ROIC | -% |
| Net Debt/EBITDA | 100.0 |